Show Sidebar

Episode 453: Michael Monovoukas – CEO & Co-Founder, AcuityMD

Episode 453 of The VentureFizz Podcast features Michael Monovoukas, Co-Founder & CEO of AcuityMD.

Sometimes the initial idea for a successful startup is planted in the middle of one that didn’t quite pan out. Right out of college, Mike started a medical device company with his brother called WoundStylus. During a tough hospital pitch, he never even took the prototype out of his pocket.  He won the meeting over using public clinical and quality data instead. Although the company failed, that insight really stuck with him, and it ended up being the initial inspiration behind AcuityMD.

AcuityMD is the AI platform for MedTech. Trusted by over 500 companies, commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. The company announced $80M in Series C funding back in April, with more than $150M raised to date, sitting right on the doorstep of a unicorn valuation.

In this episode, we cover:

  • Advice on running an effective customer conference, including lessons from their annual Flywheel event.
  • Mike’s background story and experience as a competitive swimmer, including winning four straight Ivy League titles as captain at Princeton.
  • Starting his first company, WoundStylus, out of college with his brother and the lessons it taught him.
  • Joining PatientPing in its earliest days and what scaling alongside Jay Desai taught him.
  • How he met his co-founders Robert Coe and Lee Smith and why they decided to create a new category in a highly regulated industry.
  • All the details on AcuityMD’s platform and its value for customers.
  • Details on their $80M Series C, hiring plans, and the mission-driven culture at AcuityMD.
  • Advice on hiring an executive team.
  • His disciplined philosophy on raising follow-on rounds of venture capital and building a self-sufficient business.
  • And so much more!

Weekly Newsletter

Your once a week email to stay connected to all things Boston Tech.